DE59202406D1 - 2,3,3a,4,5,9b-Hexahydro-1H-benzo[e]indol-Derivate. - Google Patents

2,3,3a,4,5,9b-Hexahydro-1H-benzo[e]indol-Derivate.

Info

Publication number
DE59202406D1
DE59202406D1 DE59202406T DE59202406T DE59202406D1 DE 59202406 D1 DE59202406 D1 DE 59202406D1 DE 59202406 T DE59202406 T DE 59202406T DE 59202406 T DE59202406 T DE 59202406T DE 59202406 D1 DE59202406 D1 DE 59202406D1
Authority
DE
Germany
Prior art keywords
lower alkyl
denotes
hexahydro
cis
indole derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE59202406T
Other languages
German (de)
English (en)
Inventor
Hans Bruderer
Thierry Godel
Rene Imhof
Roland Jakob-Roetne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of DE59202406D1 publication Critical patent/DE59202406D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/60Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE59202406T 1991-12-20 1992-12-09 2,3,3a,4,5,9b-Hexahydro-1H-benzo[e]indol-Derivate. Expired - Fee Related DE59202406D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH380691 1991-12-20
CH325492 1992-10-19

Publications (1)

Publication Number Publication Date
DE59202406D1 true DE59202406D1 (de) 1995-07-06

Family

ID=25692569

Family Applications (1)

Application Number Title Priority Date Filing Date
DE59202406T Expired - Fee Related DE59202406D1 (de) 1991-12-20 1992-12-09 2,3,3a,4,5,9b-Hexahydro-1H-benzo[e]indol-Derivate.

Country Status (21)

Country Link
US (2) US5318966A (en:Method)
EP (1) EP0548664B1 (en:Method)
JP (1) JPH07119215B2 (en:Method)
CN (1) CN1037510C (en:Method)
AT (1) ATE123277T1 (en:Method)
AU (1) AU661076B2 (en:Method)
BG (1) BG61186B1 (en:Method)
CA (1) CA2084442A1 (en:Method)
CZ (1) CZ381092A3 (en:Method)
DE (1) DE59202406D1 (en:Method)
DK (1) DK0548664T3 (en:Method)
ES (1) ES2073847T3 (en:Method)
FI (1) FI925774A7 (en:Method)
GR (1) GR3017256T3 (en:Method)
HU (2) HUT68178A (en:Method)
IL (1) IL104080A (en:Method)
IS (1) IS3961A (en:Method)
MY (1) MY108026A (en:Method)
NO (1) NO179325C (en:Method)
NZ (1) NZ245463A (en:Method)
TW (1) TW239127B (en:Method)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2100886T3 (es) * 1989-07-13 1997-07-01 Upjohn Co Derivados de 2-aminotetralinas(1,2n)- y (3,2n)-carbociclicas.
US5486611A (en) * 1989-07-13 1996-01-23 The Upjohn Company Carboxamido-(1,2N)-carbocyclic-2-aminotetralin derivatives
AU639301B2 (en) * 1990-01-11 1993-07-22 Pharmacia & Upjohn Company New centrally acting 6,7,8,9-tetrahydro-3h-benz(e)indole heterocyclics
US5434170A (en) * 1993-12-23 1995-07-18 Andrulis Pharmaceuticals Corp. Method for treating neurocognitive disorders
HUT76923A (hu) * 1994-07-27 1998-01-28 Sankyo Company Limited Muszkarinreceptorokra alloszterikus hatást kifejtő heterociklusos vegyületek
US5859295A (en) * 1994-12-05 1999-01-12 University Of Kentucky Research Foundation Canavanine analogs and their use as chemotherapeutic agents
US5889006A (en) * 1995-02-23 1999-03-30 Schering Corporation Muscarinic antagonists
IL117149A0 (en) * 1995-02-23 1996-06-18 Schering Corp Muscarinic antagonists
GB9612153D0 (en) * 1996-06-11 1996-08-14 Smithkline Beecham Plc Compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1277789A (en) * 1969-09-08 1972-06-14 Logeais Labor Jacques Improvements in or relating to new polycyclic pyrrole derivatives
JPS4930836B1 (en:Method) * 1971-07-22 1974-08-16
JPS4916862A (en:Method) * 1972-06-14 1974-02-14
SE8004002L (sv) * 1980-05-29 1981-11-30 Arvidsson Folke Lars Erik Terapeutiskt anvendbara tetralinderivat
SE8302361D0 (sv) * 1983-04-27 1983-04-27 Astra Laekemedel Ab New tricyclic amines
WO1990015047A1 (en) * 1989-05-31 1990-12-13 The Upjohn Company Therapeutically useful 2-aminotetralin derivatives
ES2100886T3 (es) * 1989-07-13 1997-07-01 Upjohn Co Derivados de 2-aminotetralinas(1,2n)- y (3,2n)-carbociclicas.

Also Published As

Publication number Publication date
AU3018692A (en) 1993-06-24
JPH07119215B2 (ja) 1995-12-20
DK0548664T3 (da) 1995-09-04
FI925774L (fi) 1993-06-21
ES2073847T3 (es) 1995-08-16
IL104080A0 (en) 1993-05-13
CN1037510C (zh) 1998-02-25
BG61186B1 (bg) 1997-02-28
AU661076B2 (en) 1995-07-13
HU9203956D0 (en) 1993-03-29
US5318967A (en) 1994-06-07
FI925774A0 (fi) 1992-12-18
NO924829D0 (no) 1992-12-14
NO179325C (no) 1996-09-18
ATE123277T1 (de) 1995-06-15
FI925774A7 (fi) 1993-06-21
JPH06128228A (ja) 1994-05-10
IL104080A (en) 1997-04-15
MY108026A (en) 1996-07-30
NO179325B (no) 1996-06-10
GR3017256T3 (en) 1995-11-30
US5318966A (en) 1994-06-07
IS3961A (is) 1993-06-21
NZ245463A (en) 1995-05-26
BG97201A (bg) 1993-12-24
EP0548664B1 (de) 1995-05-31
NO924829L (no) 1993-06-21
EP0548664A1 (de) 1993-06-30
TW239127B (en:Method) 1995-01-21
HUT68178A (en) 1995-05-29
CZ381092A3 (en) 1993-09-15
CA2084442A1 (en) 1993-06-21
CN1088576A (zh) 1994-06-29

Similar Documents

Publication Publication Date Title
NO941052L (no) Benzimidazolforbindelser, deres anvendelse og fremstilling
HUT61543A (en) Process for producing serotonin antagonist indole derivatives and pharmaceutical compositions comprising same as active ingredient
ES8801247A1 (es) Un procedimiento para la preparacion de nuevos derivados de carbazolona
DK0632036T3 (da) Amidderivater med antipypercholesteræmisk aktivitet, deres fremstilling og deres terapeutiske anvendelser
NO941884L (no) 1,3-substituerte cykloalkener og cykloalkaner som sentralnervesystem-midler
MY131641A (en) Indoline derivatives, process of preparation and use
HUT62889A (en) Process for producing benzoisothiazole and benzoisoxazole-3-carboxamide derivatives and pharmaceutical compositions comprising such compounds as active ingredient
DE69216293D1 (de) 1,4-Disubstituierte Piperidinderivate, ihre Herstellung und therapeutische Verwendung
SE8307119D0 (sv) Carboxylic acid amides and their derivatives
ES2132284T3 (es) Derivados de carbamato de 2-(piperidin-4-il, piridin-4-il y tetrahidropiridin-4-il)-benzofurano-7, su preparacion y su uso como inhibidores de acetilcolinesterasa.
NO20062599L (no) Fremgangsmate for syntese av perindopril og farmasoytisk akseptable salter derav
DE59202406D1 (de) 2,3,3a,4,5,9b-Hexahydro-1H-benzo[e]indol-Derivate.
DK213290D0 (da) Treatment of cerebrovascular disorders
CA2200742A1 (en) Quinoxaline derivatives useful in therapy
FI103887B (fi) Menetelmä terapeuttisesti käyttökelpoisten imidatsolyylimetyyli-pyridiinien valmistamiseksi
EP0535250A4 (en) Novel compounds and use thereof as medicine
NO983285L (no) Pyrido-1,2,4-tiadiazin- og pyrido-1,4-tiazinderivater, deres fremstilling og anvendelse
YU9893A (sr) Derivati indola
DE69432000D1 (de) Verwendung von Tetrahydropyridinderivaten zur Herstellung von Kardioprotektiven Medikamenten
DK0573360T3 (da) Pyrrolothienopyrazinforbindelser som 5-HT3-receptorantagonister

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee